chr14-102903404-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The ENST00000392745.8(TRAF3):c.1110C>T(p.Ser370=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00158 in 1,613,988 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0072 ( 17 hom., cov: 33)
Exomes 𝑓: 0.0010 ( 10 hom. )
Consequence
TRAF3
ENST00000392745.8 synonymous
ENST00000392745.8 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.28
Genes affected
TRAF3 (HGNC:12033): (TNF receptor associated factor 3) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from, members of the TNF receptor (TNFR) superfamily. This protein participates in the signal transduction of CD40, a TNFR family member important for the activation of the immune response. This protein is found to be a critical component of the lymphotoxin-beta receptor (LTbetaR) signaling complex, which induces NF-kappaB activation and cell death initiated by LTbeta ligation. Epstein-Barr virus encoded latent infection membrane protein-1 (LMP1) can interact with this and several other members of the TRAF family, which may be essential for the oncogenic effects of LMP1. The protein also plays a role in the regulation of antiviral response. Mutations in this are associated with Encephalopathy, acute, infection-induced, herpes-specific 5. [provided by RefSeq, Jul 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 14-102903404-C-T is Benign according to our data. Variant chr14-102903404-C-T is described in ClinVar as [Benign]. Clinvar id is 473287.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-102903404-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.28 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00719 (1094/152194) while in subpopulation AFR AF= 0.0239 (993/41510). AF 95% confidence interval is 0.0227. There are 17 homozygotes in gnomad4. There are 516 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1094 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRAF3 | NM_145725.3 | c.1110C>T | p.Ser370= | synonymous_variant | 11/12 | ENST00000392745.8 | NP_663777.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRAF3 | ENST00000392745.8 | c.1110C>T | p.Ser370= | synonymous_variant | 11/12 | 1 | NM_145725.3 | ENSP00000376500 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00721 AC: 1097AN: 152076Hom.: 18 Cov.: 33
GnomAD3 genomes
AF:
AC:
1097
AN:
152076
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00238 AC: 597AN: 250884Hom.: 3 AF XY: 0.00198 AC XY: 269AN XY: 135718
GnomAD3 exomes
AF:
AC:
597
AN:
250884
Hom.:
AF XY:
AC XY:
269
AN XY:
135718
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000999 AC: 1460AN: 1461794Hom.: 10 Cov.: 31 AF XY: 0.000935 AC XY: 680AN XY: 727200
GnomAD4 exome
AF:
AC:
1460
AN:
1461794
Hom.:
Cov.:
31
AF XY:
AC XY:
680
AN XY:
727200
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00719 AC: 1094AN: 152194Hom.: 17 Cov.: 33 AF XY: 0.00693 AC XY: 516AN XY: 74412
GnomAD4 genome
AF:
AC:
1094
AN:
152194
Hom.:
Cov.:
33
AF XY:
AC XY:
516
AN XY:
74412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Herpes simplex encephalitis, susceptibility to, 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at